Market Cap

Hansa Biopharma AB Market Capitalization:

kr3.39 Billion

SEK as of July 1, 2024

US$319.2 Million

business Hansa Biopharma AB Company Profile

Hansa Biopharma AB Main Stock Listing

OMX: HNSA

Market Capitalization History of Hansa Biopharma AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Hansa Biopharma AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr1.37 B -63.43%
Jan. 1, 2023 kr3.76 B -6.17%
Jan. 1, 2022 kr4.00 B -58.97%
Jan. 1, 2021 kr9.76 B 150.52%
Jan. 1, 2020 kr3.90 B -69.99%
Jan. 1, 2019 kr12.98 B -9.52%
Jan. 1, 2018 kr14.35 B 131.09%
Jan. 1, 2017 kr6.21 B 400.00%
Jan. 1, 2016 kr1.24 B -49.77%
Jan. 1, 2015 kr2.47 B 244.06%
Jan. 1, 2014 kr718.4 M 216.26%
Jan. 1, 2013 kr227.2 M -4.15%
Jan. 1, 2012 kr237.0 M -2.09%
Jan. 1, 2011 kr242.1 M -49.13%
Jan. 1, 2010 kr475.9 M 159.59%
Jan. 1, 2009 kr183.3 M -47.88%
Jan. 1, 2008 kr351.7 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Hansa Biopharma AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Hansa Biopharma AB has the following listings and related stock indices.


Stock: OMX: HNSA

Stock: FSX: 24H

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.